植物异多聚糖类作为潜在的抗糖尿病剂:一篇评论
Current issues in molecular biology
|July 29, 2025
概括
植物异多聚糖在治疗糖尿病 (DM) 中高血糖症方面表现有前途. 这些天然化合物通过改善胰岛素分泌和肠道健康,为传统药物提供了更安全的替代品.
科学领域:
- 生物化学 生物化学
- 药理学 药理学 是一个学科.
- 营养科学 营养科学
背景情况:
- 糖尿病 (DM) 是一种全球性健康挑战,其特点是高血糖.
- 目前的抗糖尿病药物有局限性,包括长期使用和副作用.
- 植物异多聚糖是具有潜在抗糖尿病功能的天然化合物.
研究的目的:
- 审查植物异多聚糖的抗糖尿病机制.
- 探索它们对DM相关的关键生物通路的影响.
- 为其临床应用提供一个框架.
主要方法:
- 关于植物异多多糖和糖尿病的研究文献综述.
- 分析包括胰岛素分泌,胰岛素抵抗和肠道微生物群调节在内的机制.
- 综合发现以支持临床应用.
主要成果:
- 植物异多聚糖调节胰岛素分泌并降低胰岛素抵抗力.
- 他们积极改变肠道微生物群的组成.
- 这些影响有助于植物异多聚糖的低血糖活性.
结论:
- 植物异多聚糖是DM的有希望的天然治疗剂.
- 它们的机制包括改善胰岛素敏感性和肠道健康.
- 进一步的研究可以支持将它们纳入DM管理策略.
相关概念视频
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
263
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
263
Biosynthesis of Polysaccharides
93
Polysaccharides such as glycogen and starch are synthesized from nucleoside diphosphate sugars, primarily uridine diphosphate glucose (UDPG) and adenosine diphosphate glucose (ADPG). These activated glucose donors act as key intermediates in carbohydrate metabolism and biosynthesis. UDPG primarily involves glycogen synthesis in animals and many bacteria, while ADPG plays a fundamental role in starch synthesis in plants and certain bacteria.UDPG is formed when glucose-1-phosphate reacts with...
93
Oral Hypoglycemic Agents: Glinides
263
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
263
Oral Hypoglycemic Agents: Biguanides and Glitazones
304
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
304
Chemistry of Carbohydrates
75.5K
Carbohydrates are an essential part of the diet in humans and animals. Grains, fruits, and vegetables are natural sources of carbohydrates that provide energy to the body, particularly through glucose, a simple sugar that is a component of starch and an ingredient in many staple foods. The stoichiometric formula (CH2O)n, where n is the number of carbons in the molecule represents carbohydrates. In other words, the ratio of carbon to hydrogen to oxygen is 1:2:1 in carbohydrate molecules. This...
75.5K
Dipeptidyl Peptidase 4 Inhibitors
261
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
261


